JFGIW
REGN icon

Johnson Financial Group Inc (Wisconsin)’s Regeneron Pharmaceuticals REGN Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.64M Buy
3,418
+201
+6% +$154K 0.1% 110
2025
Q4 		$2.48M Buy
3,217
+71
+2% +$48.2K 0.09% 108
2025
Q3 		$1.77M Sell
3,146
-132
-4% -$74.6K 0.07% 127
2025
Q2 		$1.72M Buy
3,278
+327
+11% +$183K 0.08% 123
2025
Q1 		$1.87M Buy
2,951
+298
+11% +$205K 0.09% 115
2024
Q4 		$1.79M Sell
2,653
-160
-6% -$134K 0.08% 116
2024
Q3 		$2.96M Buy
2,813
+56
+2% +$62.3K 0.14% 86
2024
Q2 		$2.9M Buy
2,757
+1,844
+202% +$1.79M 0.14% 90
2024
Q1 		$879K Buy
913
+46
+5% +$43.7K 0.05% 130
2023
Q4 		$761K Sell
867
-256
-23% -$211K 0.04% 139
2023
Q3 		$924K Sell
1,123
-206
-16% -$162K 0.06% 118
2023
Q2 		$955K Sell
1,329
-169
-11% -$130K 0.07% 128
2023
Q1 		$1.23M Buy
1,498
+329
+28% +$248K 0.09% 97
2022
Q4 		$843K Buy
1,169
+20
+2% +$14.8K 0.07% 121
2022
Q3 		$856K Sell
1,149
-209
-15% -$132K 0.08% 113
2022
Q2 		$803K Buy
1,358
+36
+3% +$23.4K 0.06% 141
2022
Q1 		$923K Buy
1,322
+54
+4% +$34.2K 0.07% 142
2021
Q4 		$801K Buy
1,268
+113
+10% +$69.5K 0.05% 153
2021
Q3 		$699K Sell
1,155
-91
-7% -$56.5K 0.05% 152
2021
Q2 		$696K Buy
1,246
+130
+12% +$65.9K 0.05% 155
2021
Q1 		$528K Sell
1,116
-48
-4% -$23.4K 0.04% 176
2020
Q4 		$562K Sell
1,164
-36
-3% -$19.4K 0.05% 151
2020
Q3 		$672K Buy
1,200
+219
+22% +$133K 0.07% 122
2020
Q2 		$612K Sell
981
-104
-10% -$59K 0.07% 113
2020
Q1 		$530K Sell
1,085
-26
-2% -$10.7K 0.06% 131
2019
Q4 		$417K Sell
1,111
-2,110
-66% -$710K 0.04% 151
2019
Q3 		$893K Buy
3,221
+270
+9% +$79.9K 0.08% 134
2019
Q2 		$923K Buy
2,951
+682
+30% +$227K 0.08% 132
2019
Q1 		$931K Buy
2,269
+351
+18% +$145K 0.08% 130
2018
Q4 		$716K Buy
1,918
+1,868
+3,736% +$684K 0.07% 138
2018
Q3 		$20K Hold
50
– – ﹤0.01% 401
2018
Q2 		$17K Hold
50
– – ﹤0.01% 417
2018
Q1 		$17K Hold
50
– – ﹤0.01% 429
2017
Q4 		$19K Hold
50
– – ﹤0.01% 440
2017
Q3 		$22K Hold
50
– – ﹤0.01% 410
2017
Q2 		$25K Sell
50
-59
-54% -$25.8K ﹤0.01% 418
2017
Q1 		$42K Buy
109
+15
+16% +$5.56K 0.01% 418
2016
Q4 		$34K Sell
94
-100
-52% -$38K ﹤0.01% 439
2016
Q3 		$78K Buy
194
+9
+5% +$3.61K 0.01% 356
2016
Q2 		$64K Sell
185
-60
-24% -$23.1K 0.01% 416
2016
Q1 		$88K Sell
245
-25
-9% -$10.3K 0.02% 319
2015
Q4 		$147K Buy
270
+100
+59% +$54.2K 0.03% 276
2015
Q3 		$79K Hold
170
– – 0.02% 386
2015
Q2 		$87K Sell
170
-10
-6% -$4.88K 0.02% 401
2015
Q1 		$81K Hold
180
– – 0.02% 422
2014
Q4 		$74K Buy
180
+10
+6% +$3.93K 0.02% 423
2014
Q3 		$61K Hold
170
– – 0.02% 417
2014
Q2 		$48K Sell
170
-175
-51% -$51.9K 0.01% 464
2014
Q1 		$104K Hold
345
– – 0.03% 273
2013
Q4 		$95K Hold
345
– – 0.03% 282
2013
Q3 		$108K Hold
345
– – 0.03% 287
2013
Q2 		$78K Buy
+345
New +$80.3K 0.02% 359

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s REGN Position: Q1 2026 in Review

Johnson Financial Group Inc (Wisconsin) increased its Regeneron Pharmaceuticals (REGN) stake by 6.2% in Q1 2026, buying an estimated $154K and bringing the position to 3,418 shares worth $2.64M. The position accounts for 0.1% of the portfolio, ranked #110.

Johnson Financial Group Inc (Wisconsin) first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.96M in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Johnson Financial Group Inc (Wisconsin) held 3,418 shares of Regeneron Pharmaceuticals worth $2.64M as of Q1 2026.
  • Johnson Financial Group Inc (Wisconsin) bought 201 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $154K.
  • Regeneron Pharmaceuticals made up 0.1% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q1 2026, its #110 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Johnson Financial Group Inc (Wisconsin)'s Regeneron Pharmaceuticals position peaked at $2.96M in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2026, filed 7 May 2026.